Judging from your comments you don't really think much on this topic do you?....extrapolating cardiocel revenues need something like 50% revenue growth quarter on quarter to dodge a capital raising.....A cap raise of say another $20m changes valuations completely thats why the share price has been sliding for the past year and a half....I will watch the splits for valve repair surgeries done..... off topic MENA could be an interesting geographic region as I would be hesitant on porcine based patch sales in this region....interesting thought experiment!.....
Quarterly, page-70
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.00 |
Change
0.150(1.01%) |
Mkt cap ! $317.0M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.30 | $210.2K | 14.26K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $14.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.00 | 5153 | 3 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |